Active Substance: Reassortant influenza virus (live attenuated) of the following strains:
A/California/7/2009 (H1N1)pdm09 like strain, A/Victoria/361/2011 (H3N2) like strain, B/Massachusetts/2/2012 like strain
Common Name: influenza vaccine (intranasal, live attenuated)
ATC Code: J07BB03
Marketing Authorisation Holder: MedImmune LLC
Active Substance: Reassortant influenza virus (live attenuated) of the following strains: A/California/7/2009 (H1N1)pdm09 like strain, A/Victoria/361/2011 (H3N2) like strain, B/Massachusetts/2/2012 like strain
Authorisation Date: 2011-01-27
Therapeutic Area: Influenza, Human Immunization
Pharmacotherapeutic Group: Vaccines
Prophylaxis of influenza in individuals 24 months to less than 18 years of age.
The use of Fluenz should be based on official recommendations.
The marketing authorisation for Fluenz has been withdrawn at the request of the marketing authorisation holder.
Source: European Medicines Agency
Disclaimer: Every effort has been made to ensure that the information provided here is accurate, up-to-date and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. This information has been compiled for use by healthcare practitioners and consumers in the United States. The absence of a warning for a given drug or combination thereof in no way should be construed to indicate that the drug or combination is safe, effective or appropriate for any given patient. If you have questions about the substances you are taking, check with your doctor, nurse or pharmacist.